Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReabold Resources Regulatory News (RBD)

Share Price Information for Reabold Resources (RBD)

Share Price is delayed by 15 minutes
Get Live Data
81.00    -2.50 (-2.99%)
Bid:
80.00
Ask:
82.00
Spread: 2.00 (2.50%)
Market Cap: £11.75m
RBD Live PriceLast checked at - London Stock Exchange

Intraday Reabold Resources Share Chart

Contract Gain

11 Apr 2006 07:30

Adventis Group PLC11 April 2006 For release Adventis Group plc ("Adventis") Contract Gain Adventis ("ATG/L"), the multimedia marketing and advertising agency, announcesthat Affiniti UK Ltd, its Bucks-based healthcare agency has been appointed bySanofi Pasteur MSD, an existing client, to work on a campaign for a new vaccinethat could protect the elderly against shingles. An attack of shingles can be extremely painful, with around a quarter ofsufferers going on to develop post herpetic neuralgia, an often debilitatingillness which can last for months or even years. In the UK, about 250,000 peoplesuffer from shingles each year, almost half of these being over 60 years old. Affiniti won this 3-way pitch with a strong strategic approach, which furtherextends their vaccine product portfolio. Commenting, Affiniti MD, Stuart Tennant, said: "Everyone in the agency isdelighted. We continue to build market share in the healthcare sector," whereas,Charles Phillpot, Adventis CEO said in his statement for the year ended 31December 2005: "Revenue by sector grew over that achieved in the previous year." - ENDS - Editor's NotesAdventis Group plc is an AIM listed, full service marketing and advertisingagency, providing services to the property, healthcare and financial servicesindustries.Through its six operating companies the company provides a complete range ofcommunication services, including corporate identity programmes, advertisingcampaigns, media planning & buying, literature, public relation, packaging,exhibitions, research and planning, interiors, signage and digital media.Adventis employs over 80 staff in London and the South East.www.adventis.co.uk In January 2005, Adventis acquired Affiniti (UK) Ltd, a specialised UKhealthcare advertising agency with clients such as Allergan, Sanofi Pasteur MSD,Chiron Vaccines, Eden Biopharm, Leo Pharma and Serono. The acquisition hasperformed very well in 2005 with a pre-tax profit of £247,000 and builds on thefoothold Adventis Group already had in this profitable market. Enquiries: Adventis Group plcCharles Phillpot, Chief Executive Officer 020 7034 4750 Affiniti (UK) LtdStuart Tennant, Managing Director 01494 775 213 Seymour PierceJohn Depasquale 020 7107 8000 Binns & Co PR Ltd 020 7786 9600Peter Binns 07768 392 582Annie Evangeli 07778 507 162 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Jun 20237:00 amRNSTransaction in Own Shares
1st Jun 20237:00 amRNSInvestment in LNEnergy Update
1st Jun 20237:00 amRNSTransaction in Own Shares
31st May 20237:00 amRNSTransaction in Own Shares
30th May 20237:00 amRNSFull Year Results for year ended 31 December 2022
26th May 20237:00 amRNSTransaction in Own Shares
25th May 20237:00 amRNSTransaction in Own Shares
24th May 20237:00 amRNSTransaction in Own Shares
23rd May 20237:00 amRNSTransaction in Own Shares
22nd May 20237:00 amRNSTransaction in Own Shares
19th May 20237:00 amRNSTransaction in Own Shares
18th May 20237:00 amRNSTransaction in Own Shares
17th May 20237:00 amRNSTransaction in Own Shares
16th May 20237:00 amRNSTransaction in Own Shares
15th May 20237:00 amRNSTransaction in Own Shares
12th May 20237:00 amRNSTransaction in Own Shares
11th May 20237:00 amRNSTransaction in Own Shares
10th May 20237:00 amRNSTransaction in Own Shares
9th May 20237:00 amRNSInvestment in LNEnergy
9th May 20237:00 amRNSTransaction in Own Shares
5th May 20237:00 amRNSTransaction in Own Shares
4th May 20237:00 amRNSTransaction in Own Shares
3rd May 20237:00 amRNSTransaction in Own Shares
2nd May 20237:00 amRNSTransaction in Own Shares
28th Apr 202311:53 amRNSLong Term Incentive Plan Awards
28th Apr 20237:00 amRNSOperational Update & Share Buyback
12th Apr 20231:09 pmRNSStatement re Portillion and End of Offer Period
12th Apr 202312:13 pmRNSRule 2.8 Announcement
11th Apr 202312:00 pmRNSForm 8.5 (EPT/RI) - Reabold Resources plc
6th Apr 202312:00 pmRNSForm 8.5 (EPT/RI) - Reabold Resources plc
3rd Apr 202312:00 pmRNSForm 8.5 (EPT/RI) - Reabold Resources plc
31st Mar 20233:41 pmRNSForm 8.3 - Reabold Resources PLC
31st Mar 20233:35 pmRNSForm 8 (OPD) - Reabold Resources PLC
31st Mar 202312:00 pmRNSForm 8.5 (EPT/RI) - Reabold Resources plc
30th Mar 202312:52 pmRNSForm 8.3 - Reabold Resources PLC
30th Mar 202312:00 pmRNSForm 8.5 (EPT/RI) - Reabold Resources plc
29th Mar 20232:06 pmRNSForm 8.3 - Reabold Resources PLC
29th Mar 202312:44 pmRNSCapital Reduction Update
27th Mar 20235:15 pmRNSForm 8 (OPD) - Reabold Resources PLC
27th Mar 20232:07 pmRNSForm 8.3 - Reabold Resources PLC
27th Mar 202312:00 pmRNSForm 8.5 (EPT/RI) - Reabold Resources plc
24th Mar 202312:00 pmRNSForm 8.5 (EPT/RI) - Reabold Resources plc
23rd Mar 20236:22 pmRNSForm 8.3 - Reabold Resources plc
23rd Mar 20236:22 pmRNSForm 8.3 - Reabold Resources plc
23rd Mar 20231:19 pmRNSForm 8.3 - Reabold Resources PLC
23rd Mar 202312:00 pmRNSForm 8.5 (EPT/RI) - Reabold Resources plc
20th Mar 20237:00 amRNSNew Corporate Presentation
17th Mar 20231:15 pmRNSForm 8.3 - Reabold Resources plc
16th Mar 20233:33 pmEQSForm 8.3 - Maitland Institutional Services Limited: Re Reabold Resources Plc
16th Mar 202312:26 pmRNSForm 8.3 - Reabold Resources PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.